Ask Mesoblast how good mesenchymal stromal cells a
Post# of 148165
Maximum age 77.4, severe only disease yet a 23% death rate in the SOC arm. That sounds a bit high to me. The mortality in the SOC arm is one of the first things I look for anymore because some studies have claimed massively high death rates.
When you look at the clinical trial protocol even though it's a phase 1/2 it's primary outcome is - No treatment-related adverse reactions. Mortality is not even listed as an outcome and enrollment is 35 patients.